Hepa 1-6
Strain Information
表現型データ
I. Characterization of in vivo growth kinetics
The Hepa1-6 cells were subcutaneously inoculated into the C57BL/6 mice.
Figure 1. Tumor growth curve of Hepa1-6 allogeneic model (n=6)
Figure 2. Body weight change of Hepa1-6 allogeneic model (n=6)
*Wild-type cell lines are not for sale, and only applled to construction of tumor bearing mice and in-vivo efficacy studies.
関連の系統
あなたも好きかも
On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.
詳細At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.
詳細